ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,482Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 197

$1.43M Total Retail Price of All Prescriptions

Rank: 6 out of 197

591 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 12,486 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$99 was the average price of a prescription from this provider, compared to $130 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
NAMENDA 1,230 1,195 1 21
FLUOXETINE HCL 846 799 2 12
DONEPEZIL HCL 646 611 3 27
EXELON 598 565 4 46
PRAVASTATIN SODIUM 594 536 5 57
GABAPENTIN 502 409 6 31
LAMOTRIGINE 388 263 7 16
MIRTAZAPINE 331 319 8 9
TRAZODONE HCL 301 222 9 1
OLANZAPINE 270 256 10 13
CYMBALTA 265 239 11 5
CARBAMAZEPINE 261 203 12 43
ABILIFY 242 165 13 10
LEVOTHYROXINE SODIUM 221 190 14 42
PANTOPRAZOLE SODIUM 218 208 15 67
AMLODIPINE BESYLATE 212 199 16 47
MISOPROSTOL 202 178 17 90
CLONAZEPAM 199 195 18 39
BUSPIRONE HCL 196 153 19 26
ROPINIROLE HCL 188 157 20 78
MEXILETINE HCL 185 178 10 21 92
ESCITALOPRAM OXALATE 178 137 22 15
QUETIAPINE FUMARATE 171 126 23 3
CITALOPRAM HBR 129 118 24 8
PRISTIQ ER 125 103 25 36
DIVALPROEX SODIUM 124 91 26 20
DIVALPROEX SODIUM ER 122 78 27 6
OMEPRAZOLE 117 108 28 35
DOXAZOSIN MESYLATE 115 104 29 108
PAROXETINE HCL 113 110 30 25
LISINOPRIL 112 111 31 49
VENLAFAXINE HCL ER 112 90 31 14
LITHIUM CARBONATE 112 67 31 18
SEROQUEL XR 109 70 34 22
TAMSULOSIN HCL 104 97 35 87
RIVASTIGMINE 103 92 36 97
BUPROPION XL 100 87 37 19
FUROSEMIDE 93 83 38 59
GABITRIL 91 43 10 39 114
SAPHRIS 86 63 40 69
RAMIPRIL 82 79 41 116
METOPROLOL TARTRATE 80 68 42 70
LEVETIRACETAM 74 24 43 102
ZYPREXA 73 59 44 63
GALANTAMINE HBR 72 72 45 102
SEROQUEL 69 54 46 17
CEREFOLIN NAC 68 68 10 47 121
TOPIRAMATE 68 30 47 36
LEXAPRO 67 51 49 51
AMITRIPTYLINE HCL 66 47 R 50 38
CARVEDILOL 65 64 51 123
POTASSIUM CHLORIDE 64 60 52 84
ZIPRASIDONE HCL 63 34 53 24
ATENOLOL 61 60 54 95
AZILECT 57 47 55 132
GLYCOPYRROLATE 56 46 56 134
IMIPRAMINE HCL 54 45 R 57 81
ARICEPT 54 54 57 137
DOXEPIN HCL 54 54 57 48
L-METHYLFOLATE-MECOBALAMIN-NAC 53 53 10 60 139
METFORMIN HCL 52 42 61 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.